NeoGenomics, Inc. Impairment of Long-Lived Assets to be Disposed of
NeoGenomics, Inc. (NEO) reported Impairment of Long-Lived Assets to be Disposed of of $226.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2023-11-06
- NeoGenomics, Inc. impairment of long-lived assets to be disposed of for the quarter ending 2023-09-30 was $226.00K.
- NeoGenomics, Inc. impairment of long-lived assets to be disposed of for the quarter ending 2023-06-30 was $329.00K.
- NeoGenomics, Inc. impairment of long-lived assets to be disposed of for the quarter ending 2023-03-31 was $560.00K.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 9 month |
|---|---|---|---|
| 2023-09-30 | $226.00K 10-Q · filed 2023-11-06 | $555.00K derived: sum of 2 quarters · filed 2023-11-06 | $1.11M derived: sum of 3 quarters · filed 2023-11-06 |
| 2023-06-30 | $329.00K 10-Q · filed 2023-11-06 | $889.00K derived: sum of 2 quarters · filed 2023-11-06 | |
| 2023-03-31 | $560.00K 10-Q · filed 2023-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |